@article {2999,
	title = {Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage?},
	journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
	volume = {47},
	year = {2008},
	month = {2008 Nov 1},
	pages = {1226-30},
	abstract = {The US Food and Drug Administration has issued a warning that tipranavir may be associated with increased risk of intracranial hemorrhage. We studied 2 large cohorts to estimate the background rate of intracranial hemorrhage and compared it with rates reported among persons who had been exposed to tipranavir.},
	keywords = {Adult, Age Factors, Anti-HIV Agents, California, Cohort Studies, Databases, Factual, Female, HIV Infections, Humans, Intracranial Hemorrhages, Male, Medicaid, Middle Aged, Pyridines, Pyrones, Risk Factors, United States, Veterans},
	issn = {1537-6591},
	doi = {10.1086/592302},
	author = {Justice, Amy C and Zingmond, David S and Gordon, Kirsha S and Fultz, Shawn L and Goulet, Joseph L and King, Joseph T and Bravata, Dawn M and Valdez, Hernan and Kraft, Michael and Mattocks, Kristin M}
}
